G Nib Strip Of 10 Tablets
10 Tablet(s) in StripMRP ₹439.85
₹329.89
25% OFF
Made by
WALLACE PHARMACEUTICALS
Dosage
TABLET
Expiry
Product Summary
| Uses | Non-small cell lung cancer, Locally advanced lung cancer, Metastatic lung cancer |
| Therapy | Drugs for chronic idiopathic myelofibrosis, anti-neoplastic |
| Side effects | Diarrhea, Skin rash, Nausea, Vomiting |
Assurance
available
Regulated
Medical Description
G Nib tablet is a targeted therapy medicine used to treat a specific type of lung tumour that carries certain genetic mutations. It contains gefitinib, which works by blocking abnormal growth signals inside these cells.
Uses
- Non-small cell lung cancer
- Locally advanced lung cancer
- Metastatic lung cancer
Contraindications
Side effects
- Diarrhea
- Skin rash
- Nausea
- Vomiting
Precautions and Warnings
Pregnancy
Breast Feeding
Alcohol
Driving
Other General Warnings
- You experience sudden breathing difficulties, cough, or fever, which require immediate evaluation for lung inflammation.
- You develop severe, persistent diarrhea that does not respond to anti-diarrheal treatment.
- You notice signs of liver problems, such as yellowing of the skin or eyes, dark urine, or upper abdominal pain.
- You experience severe eye pain, redness, blurred vision, or eye watering.
Directions for Use
Storage and disposal
Quick Tips
- Your doctor will monitor your liver function regularly with blood tests
- Drink plenty of fluids if diarrhea occurs
- Inform your doctor immediately if you develop a persistent cough, shortness of breath, or difficulty breathing
- Use effective birth control during treatment, as this medicine can harm a developing fetus
- Continue taking this medicine as long as your doctor advises for best results
Dosage
Missed a Dose
Overdose
How does this medicine work?
Interactions
Interactions with other medicines
Interactions with food items
Frequently Asked Questions (FAQs)
References:
- Central Drugs Standard Control Organisation (CDSCO). Drugs@CDSCO [Internet]. New Delhi: Directorate General of Health Services, Ministry of Health & Family Welfare, Government of India; [cited 2026 Aug 24].
- electronic medicines compendium (emc). Gefitinib 250 mg film-coated tablets - Summary of Product Characteristics (SmPC) [Internet]. Sandwich: Accord-UK Ltd; 2023 [cited 2026 Aug 24].
- electronic medicines compendium (emc). Gefitinib 250 mg film-coated tablets - Patient Information Leaflet (PIL) [Internet]. Sandwich: Accord-UK Ltd; 2023 [cited 2026 Aug 24].
- Danish Medicines Agency. Gefitinib Risk Management Plan (RMP) summary [Internet]. Copenhagen: Lægemiddelstyrelsen; 2021 [cited 2026 Aug 24].
- Cipla Ltd. Gefticip Tablets Product Information [Internet]. Mumbai: Ciplamed; 2022 [cited 2026 Aug 24].
- Health Canada. Gefitinib tablets Product Monograph [Internet]. Ottawa: Health Canada; 2020 [cited 2026 Aug 24].
Articles
View All
Chronic Condition Articles
View All
Did you find this helpful?
Explore More at Pharmeasy
Manufacturer Details
Brand:G NIB
Vendor Details
Fulfillment Information: G Nib Tablet (10) will be delivered by a licensed retail pharmacy nearest to your location. Order acceptance and fulfillment are dependent upon the verification of your doctor's valid prescription (where applicable) and the current stock of this medicine.
In Case of Any Issues Contact Us
Email Id:care@pharmeasy.in
Phone Number:7666100300
Address:D-37/1, Opp. Sandoz, TTC Industrial Area, MIDC Industrial Area, Turbhe, Navi Mumbai, Maharashtra 400703
Disclaimer
The information provided herein is supplied to the best of our abilities to make it accurate and reliable as it is published after a review by a team of professionals. This information is solely intended to provide a general overview on the product and must be used for informational purposes only. You should not use the information provided herein to diagnose, prevent, or cure a health problem. Nothing contained on this page is intended to create a doctor-patient relationship, replace or be a substitute for a registered medical practitioner's medical treatment/advice or consultation. The absence of any information or warning to any medicine shall not be considered and assumed as an implied assurance. We highly recommend that you consult your registered medical practitioner for all queries or doubts related to your medical condition. You hereby agree that you shall not make any health or medical-related decision based in whole or in part on anything contained in the Site. Please click here for detailed T&C.
